Literature DB >> 7059476

The penetration of misonidazole into a mature structural cartilage.

A J Langler, R D Bugden, P Gibson.   

Abstract

Mature cartilage may be expected to contain populations of hypoxic cells as a result of the tissues lack of direct vascularization and structure; it may therefore be at risk from possible radiosensitization. The hypoxic-cell radiosensitizing drug misonidazole Ro-07-0582 (MISO) was administered i.v. to mature New Zealand White rabbits at a dose of 100 mg/kg, and the resulting drug concentrations in both blood and ear-cartilage samples measured by HPLC. Samples were taken at regular intervals up to 4 h after administration of MISO. Blood concentrations of MISO rose rapidly to 240 microgram/ml within 5 min of administration, before falling steadily, with a t1/2 of 45 min. Cartilage levels reached a peak of 70% of the blood levels approximately 30 min after administration. The levels of MISO then fell, with a t1/2 of 44 min.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059476      PMCID: PMC2010886          DOI: 10.1038/bjc.1982.44

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Measurement of pH and ionic composition of pericellular sites.

Authors:  I A Silver
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1975-07-17       Impact factor: 6.237

2.  The pharmacokinetics of misonidazole in the dog.

Authors:  R A White; P Workman; L S Freedman; L N Owen; N M Bleehen
Journal:  Eur J Cancer       Date:  1979-10       Impact factor: 9.162

3.  Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.

Authors:  P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Misonidazole blood and cerebrospinal fluid kinetics in monkeys following intravenous and intrathecal administration.

Authors:  D Gangji; D G Poplack; J Schwade; J H Wood; J M Strong
Journal:  Eur J Cancer       Date:  1981-01       Impact factor: 9.162

5.  Hypoxic cell sensitization by misonidazole in vivo and in vitro.

Authors:  N J McNally; J Denekamp; P W Sheldon; I R Flockhart
Journal:  Br J Radiol       Date:  1978-04       Impact factor: 3.039

6.  Clinical studies with misonidazole.

Authors:  C R Wiltshire; P Workman; J V Watson; N M Bleehen
Journal:  Br J Cancer Suppl       Date:  1978-06

7.  Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative.

Authors:  R C Urtasun; P Band; J D Chapman; H R Rabin; A F Wilson; C G Fryer
Journal:  Radiology       Date:  1977-03       Impact factor: 11.105

8.  The toxicity of the radiosensitizer misonidazole towards hypoxic cells in vitro: a model for mouse and man.

Authors:  I J Stratford; G E Adams
Journal:  Br J Radiol       Date:  1978-09       Impact factor: 3.039

9.  Distribution of misonidazole in human tumours and normal tissues.

Authors:  D V Ash; M R Smith; R D Bugden
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640

10.  Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.

Authors:  J E Pedersen; M R Smith; R D Bugden; M J Peckham
Journal:  Br J Cancer       Date:  1979-04       Impact factor: 7.640

View more
  2 in total

1.  Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography.

Authors:  G Akel; P Benard; P Canal; G Soula
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Microscopic distribution of misonidazole in mouse tissues.

Authors:  L M Cobb; J Nolan; P O'Neill
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.